(2S)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine
Structure Info
- Chemspace ID
- CSSB20809181634 (In-Stock Building Blocks)
- IUPAC Name
- (2S)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine
- Mol formula
- C20H28BNO3
- Mol weight
- 341 Da
- Catalog Number(s)
- BBLS20809181634, BBV-1687673413, EN300-55398941, bbls20809181634
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 4.1
- Heavy atoms count
- 25
- Rotatable bond count
- 3
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.65
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of (2S)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine (C20H28BNO3) - CSSB20809181634](/st/structure/200/10c7aaa0b363d718f4b34973f3f4c1ea/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D1C1CCC1.png "C20H28BNO3")
- Zoom the structure
- CSSB20809181634
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of (2R)-2-cyclobutyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB20809158062](/st/structure/200/57a89fbb1abeb4228092d4b6933c752f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540%2540H%255D1C1CCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB02229494050](/st/structure/200/3a64b9a1e7d70d1627e5df84fcfa78fa/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC2CCCC12.png)
![Chemical structure of rac-(3aR,6aR)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-octahydrocyclopenta[b]pyrrole - CSSB21332841571](/st/structure/200/591f342d23d3daa349808c4c1d4360cb/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CCC%255BC%2540%2540H%255D12%2B%257C%25261%253A20%252C24%252Cr%257C.png)
![Chemical structure of 2-cyclopropyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02195989487](/st/structure/200/4f7bffd8be0d12b5aca8dc756b2e6fa2/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC1C1CC1.png)
![Chemical structure of rac-(1R,5R)-2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-2-azabicyclo[3.2.0]heptane - CSSB21332840848](/st/structure/200/b42dee1b8d7b5ee8c4b436fb3fad5ef7/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%2528%253DCC%253DC1%2529C%2528%253DO%2529N1CC%255BC%2540H%255D2CC%255BC%2540%2540H%255D12%2B%257C%25261%253A20%252C23%252Cr%257C.png)
![Chemical structure of 2-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-2-azabicyclo[4.1.0]heptane - CSSB02195990991](/st/structure/200/45e35ab48a9e97db14d9c385c3bb4847/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCC2CC12.png)
![Chemical structure of 2-(propan-2-yl)-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB02195989026](/st/structure/200/567a72aab9e56cc125d1df8503d51773/CC%2528C%2529C1CCN1C%2528%253DO%2529C1%253DCC%253DCC%2528%253DC1%2529B1OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O1.png)
